Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 27401
Tytuł:
Development and validation of a predictive model for the diagnosis of bladder tumors using narrow band imaging.
Autorzy:
Liang H; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Yang Q; Department of Urology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China.
Zhang Y; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Sun H; Department of Urology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China.
Fu Q; Department of Urology, Shandong Provincial Hospital, Jinan, Shandong, China.
Diao T; Department of Urology, Shandong Provincial Hospital, Jinan, Shandong, China.
Wang J; Department of Urology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Huang W; Department of Urology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Xu Y; Department of Urology, The Second Hospital of Shandong University, Jinan, Shandong, China.
Ge N; Department of Urology, The Second Hospital of Shandong University, Jinan, Shandong, China.
Jiang X; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Chen S; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Li Y; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhou B; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Li P; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhang X; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zhang N; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Shi B; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Chen J; Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Nov; Vol. 149 (17), pp. 15867-15877. Date of Electronic Publication: 2023 Sep 06.
Typ publikacji:
Journal Article
MeSH Terms:
Narrow Band Imaging*/methods
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Humans ; Nomograms ; Cystoscopy/methods ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease.
Autorzy:
Miyake M; Department of Urology, Nara Medical University, Nara, Japan.
Nishimura N; Department of Urology, Nara Medical University, Nara, Japan.
Fujii T; Department of Diagnostic Pathology, Nara Medical University, Nara, Japan.
Fujimoto K; Department of Urology, Nara Medical University, Nara, Japan.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Nov; Vol. 30 (11), pp. 944-957. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/drug therapy
Humans ; BCG Vaccine/therapeutic use ; Adjuvants, Immunologic ; Neoplasm Staging ; Administration, Intravesical ; Risk Assessment/methods ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guérin for non-muscle invasive bladder cancer.
Autorzy:
Alam SM; Department of Urology, University of Kansas Health System, Kansas City, KS.
Larson M; Department of Urology, University of Kansas Health System, Kansas City, KS.
Srinivasan P; Department of Dietetics and Nutrition, University of Kansas, Kansas City, KS.
Genz N; Department of Urology, University of Kansas Health System, Kansas City, KS.
Fleer R; Department of Pharmacy Practice, University of Kansas Health System, Kansas City, KS.
Sardiu M; Department of Biostatistics, University of Kansas, Kansas City, KS.
Thompson J; Department of Biostatistics, University of Kansas, Kansas City, KS.
Lee E; Department of Urology, University of Kansas Health System, Kansas City, KS.
Hamilton-Reeves J; Department of Urology, University of Kansas Health System, Kansas City, KS; Department of Dietetics and Nutrition, University of Kansas, Kansas City, KS; Department of Medicine, Division of Medical Oncology, University of Kansas, Kansas City, KS.
Wulff-Burchfield E; Department of Medicine, Division of Medical Oncology, University of Kansas, Kansas City, KS. Electronic address: .
Pokaż więcej
Źródło:
Urologic oncology [Urol Oncol] 2023 Oct; Vol. 41 (10), pp. 431.e15-431.e20. Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Sarcopenia*/epidemiology
Sarcopenia*/etiology
Frailty*/epidemiology
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/drug therapy
Male ; Female ; Humans ; BCG Vaccine/adverse effects ; Administration, Intravesical ; Neoplasm Invasiveness ; Adjuvants, Immunologic/therapeutic use ; Neoplasm Recurrence, Local
Czasopismo naukowe
Szczegóły
Tytuł:
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study.
Autorzy:
Nishiyama H; Department of Urology, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
Tsuzuki T; Department of Surgical Pathology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan.
Ohyama C; Department of Urology, Hirosaki University, 5 Zaifu-Cho, Hirosaki, Aomori, 036-8562, Japan.
Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan.
Shinozaki K; AstraZeneca K.K, 3-1 Ofukacho, Kita-Ku, Osaka, 530-0011, Japan.
Hayashi Y; AstraZeneca K.K, 3-1 Ofukacho, Kita-Ku, Osaka, 530-0011, Japan.
Hayashi N; AstraZeneca K.K, 3-1 Ofukacho, Kita-Ku, Osaka, 530-0011, Japan.
Koto R; AstraZeneca K.K, 3-1 Ofukacho, Kita-Ku, Osaka, 530-0011, Japan.
Shin E; AstraZeneca K.K, 3-1 Ofukacho, Kita-Ku, Osaka, 530-0011, Japan.
Ogawa O; Department of Urology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu, Shiga, 520-8511, Japan. .
Pokaż więcej
Źródło:
International journal of clinical oncology [Int J Clin Oncol] 2023 Oct; Vol. 28 (10), pp. 1398-1410. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/genetics
Carcinoma, Transitional Cell*/drug therapy
Antineoplastic Agents, Immunological*/therapeutic use
Lung Neoplasms*/pathology
Adult ; Humans ; Aged ; B7-H1 Antigen/genetics ; Retrospective Studies ; Mutation ; Biomarkers, Tumor/genetics ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
Autorzy:
Kimura K; Department of Diagnostic Radiology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Yoshida S; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan. .
Tsuchiya J; Department of Diagnostic Radiology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Kitazume Y; Department of Diagnostic Radiology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Waseda Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Tanaka H; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Yokoyama M; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Toda K; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Yoshimura R; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Masaya I; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Koga F; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Tateishi U; Department of Diagnostic Radiology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Fujii Y; Department of Urology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Pokaż więcej
Źródło:
European radiology [Eur Radiol] 2023 Sep; Vol. 33 (9), pp. 6245-6255. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Urinary Bladder*/pathology
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Magnetic Resonance Imaging/methods ; Chemoradiotherapy ; Muscles/pathology ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI.
Autorzy:
Woo S; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. .; Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA. .
Becker AS; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA.
Das JP; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Ghafoor S; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, Zürich, CH-8091, Switzerland.
Arita Y; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Benfante N; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Gangai N; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Teo MY; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Goh AC; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA.
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2023 Nov 14; Vol. 23 (1), pp. 110. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Multiparametric Magnetic Resonance Imaging*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/drug therapy
Male ; Humans ; Female ; Aged ; Neoadjuvant Therapy/methods ; Neoplasm, Residual ; Muscles/pathology ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway.
Autorzy:
Møller CT; Department of Research, Cancer Registry of Norway, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. .
Tafjord G; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Blindheim A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Berge V; Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Urology, Oslo University Hospital, Oslo, Norway.
Fosså S; Faculty of Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
Andreassen BK; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 Nov 10; Vol. 58, pp. 101-108. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/therapy
Humans ; Combined Modality Therapy ; Cystectomy/methods ; Immunotherapy ; Norway ; Neoplasm Metastasis
Czasopismo naukowe
Szczegóły
Tytuł:
Screening for a practical method to monitor the status of patients with metastatic bladder cancer at the circulating cell-gene level.
Autorzy:
Ogura R; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Ito S; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Ueda T; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan. .
Gabata Y; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Sako S; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Inoue Y; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Yamada T; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Konishi H; Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.
Fujihara A; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Ukimura O; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, 602-8566, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 09; Vol. 13 (1), pp. 19517. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Cell-Free Nucleic Acids*
Telomerase*/genetics
Humans ; Promoter Regions, Genetic ; Early Detection of Cancer ; Mutation ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cigarette Smoking, Smoking Cessation, and Bladder Cancer Risk: A Pooled Analysis of 10 Cohort Studies in Japan.
Autorzy:
Masaoka H; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute.; Department of Urology, Kyushu Central Hospital.
Matsuo K; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute.; Department of Epidemiology, Nagoya University Graduate School of Medicine.
Oze I; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute.
Kimura T; Department of Public Health, Hokkaido University Graduate School of Medicine.
Tamakoshi A; Department of Public Health, Hokkaido University Graduate School of Medicine.
Sugawara Y; Division of Epidemiology, Department of Health Informatics and Public Health, Tohoku University School of Public Health, Graduate School of Medicine.
Tsuji I; Division of Epidemiology, Department of Health Informatics and Public Health, Tohoku University School of Public Health, Graduate School of Medicine.
Sawada N; Division of Cohort Research, National Cancer Center Institute for Cancer Control.
Tsugane S; Division of Cohort Research, National Cancer Center Institute for Cancer Control.
Ito H; Department of Epidemiology, Nagoya University Graduate School of Medicine.; Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute.
Wada K; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine.
Nagata C; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine.
Kitamura T; Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine.
Zha L; Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine.
Sakata R; Department of Epidemiology, Radiation Effects Research Foundation.
Ozasa K; Department of Epidemiology, Radiation Effects Research Foundation.
Lin Y; Department of Public Health, Aichi Medical University School of Medicine.
Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine.
Tanaka K; Department of Preventive Medicine, Faculty of Medicine, Saga University.
Abe SK; Division of Prevention, National Cancer Center Institute for Cancer Control.
Inoue M; Division of Cohort Research, National Cancer Center Institute for Cancer Control.; Division of Prevention, National Cancer Center Institute for Cancer Control.
Pokaż więcej
Źródło:
Journal of epidemiology [J Epidemiol] 2023 Nov 05; Vol. 33 (11), pp. 582-588. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cigarette Smoking*
Smoking Cessation*
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/etiology
Male ; Humans ; Female ; Japan/epidemiology ; Cohort Studies ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Differences in clinical features between focal and extensive types of cystitis glandularis in patients without a previous history of urinary tract malignancy.
Autorzy:
Jeon J; Department of Urology, Prostate Cancer Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Ha JS; Department of Urology, Prostate Cancer Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Shin SJ; Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Ham WS; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Choi YD; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Cho KS; Department of Urology, Prostate Cancer Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.; Center of Evidence Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2023 Nov; Vol. 64 (6), pp. 597-605.
Typ publikacji:
Journal Article
MeSH Terms:
Cystitis*
Urinary Bladder Neoplasms*/pathology
Urologic Neoplasms*/pathology
Female ; Humans ; Male ; Cystoscopy ; Urinary Bladder/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma.
Autorzy:
Dursun F; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA. .
Elshabrawy A; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.
Wang H; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.
Kaushik D; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.; UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.
Liss MA; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.; UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.
Svatek RS; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.; UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.
Gore JL; Department of Urology, University of Washington, Seattle, WA, USA.
Mansour AM; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.; UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA.; Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2023 Nov; Vol. 64 (6), pp. 561-571.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/pathology
Carcinoma*/surgery
Humans ; Urinary Bladder/pathology ; Rural Population ; Cystectomy ; Muscles/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cancer trial results show power of weaponized antibodies.
Autorzy:
Ledford H
Pokaż więcej
Źródło:
Nature [Nature] 2023 Nov; Vol. 623 (7986), pp. 231-232.
Typ publikacji:
Wiadomości
MeSH Terms:
Antibodies, Neoplasm*/immunology
Antibodies, Neoplasm*/therapeutic use
Clinical Trials as Topic*
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/immunology
Humans ; Immunoconjugates/chemistry ; Immunoconjugates/immunology ; Immunoconjugates/therapeutic use ; Treatment Outcome
Periodyk
Szczegóły
Tytuł:
Diagnostic and prognostic impact of preoperative thrombocytosis in muscle invasive bladder cancer: Any role in clinical practice?
Autorzy:
Sretenovic M; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.
Bojanic N; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Grozdic Milojevic I; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.; Center of Nuclear Medicine, University Clinical Center of Serbia, Belgrade, Serbia.
Bumbasirevic U; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Radisavcevic D; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.
Bulat P; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.
Sipetic Grujicic S; Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Milojevic B; Clinic of Urology, University Clinical Center of Serbia, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Pokaż więcej
Źródło:
Journal of clinical ultrasound : JCU [J Clin Ultrasound] 2023 Nov-Dec; Vol. 51 (9), pp. 1607-1614. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/complications
Urinary Bladder Neoplasms*/surgery
Thrombocytosis*/complications
Thrombocytosis*/epidemiology
Carcinoma*/complications
Carcinoma*/surgery
Anemia*/complications
Anemia*/surgery
Hydronephrosis*
Humans ; Prognosis ; Retrospective Studies ; Cystectomy/methods ; Muscles/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.
Autorzy:
Santini D; Medical Oncology A, University of Rome, Policlinico Umberto I, 'La Sapienza, Rome, Italy.
Banna GL; Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, PO1 2UP, UK.
Buti S; Department of Medicine and Surgery, University of Parma, Viale A. Gramsci 14, 43126, Parma, Italy. .; Oncology Unit, University Hospital of Parma, Viale A. Gramsci 14, 43126, Parma, Italy. .
Isella L; Department of Medicine and Surgery, University of Parma, Viale A. Gramsci 14, 43126, Parma, Italy.
Stellato M; Medical Oncology Department, Fondazione IRCCS National Cancer Institute, Milan, Italy.
Roberto M; UOC Oncology A, Department of Radiological, Oncological and Anatomo-Pathological Science, Policlinico Umberto I, 'La Sapienza' University of Rome, Rome, Italy.
Iacovelli R; UOC Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Pokaż więcej
Źródło:
Current oncology reports [Curr Oncol Rep] 2023 Nov; Vol. 25 (11), pp. 1345-1362. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Antineoplastic Agents*/therapeutic use
Humans ; Cisplatin/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
A HER2-targeted Antibody-Drug Conjugate, RC48-ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer.
Autorzy:
Hong X; Department of Urology, Shantou Central Hospital, Shantou, Guangdong, 515031, P. R. China.; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.
Chen X; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.
Wang H; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.
Xu Q; Department of Urology, Shantou Central Hospital, Shantou, Guangdong, 515031, P. R. China.
Xiao K; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.
Zhang Y; Department of Urology, Shantou Central Hospital, Shantou, Guangdong, 515031, P. R. China.
Chi Z; Department of Urology, Shantou Central Hospital, Shantou, Guangdong, 515031, P. R. China.
Liu Y; Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.
Liu G; School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510120, P. R. China.
Li H; BioMed Laboratory, Guangzhou Jingke Biotech Group, Guangzhou, Guangdong, 510120, P. R. China.
Fang J; RemeGen, Ltd., Yantai, Shandong, 264006, P. R. China.; School of Life Science and Technology, Tongji University, Shanghai, 200092, P. R. China.
Lin T; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510120, P. R. China.; Guangdong Provincial Clinical Research Centre for Urological Diseases, Guangzhou, Guangdong, 510120, P. R. China.
Zhang Y; Department of Urology, Shantou Central Hospital, Shantou, Guangdong, 515031, P. R. China.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Nov; Vol. 10 (32), pp. e2302377. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunoconjugates*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Animals ; Mice ; Humans ; Administration, Intravesical ; Apoptosis ; Mice, Nude ; Cell Line, Tumor ; Neoplasm Recurrence, Local/drug therapy ; G2 Phase Cell Cycle Checkpoints
Czasopismo naukowe
Szczegóły
Tytuł:
Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer.
Autorzy:
Liang T; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Tao T; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Wu K; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Liu L; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Xu W; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Zhou D; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Fang H; Department of Urology, South China Hospital of Shenzhen University, Shenzhen, 518000, China.
Ding Q; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.
Huang G; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.
Wu S; Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, 518116, China.; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 518000, China.; Department of Urology, South China Hospital of Shenzhen University, Shenzhen, 518000, China.
Pokaż więcej
Źródło:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Nov; Vol. 10 (31), pp. e2303230. Date of Electronic Publication: 2023 Sep 24.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Animals ; Mice ; Tumor Microenvironment ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Monocytes ; Chronic Disease
Czasopismo naukowe
Szczegóły
Tytuł:
Effect of obturator nerve block during transurethral resection of bladder tumors on the disease recurrence, progression and surgery outcomes.
Autorzy:
Gercek O; Department of Urology, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. .
Keles I; Department of Urology, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Saritas TB; Department of Anesthesiology and Reanimation, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Koyuncu B; Department of Anesthesiology and Reanimation, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Topal K; Department of Urology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey.
Demirbas A; Department of Urology, Bursa Doruk Hospital, Bursa, Turkey.
Pokaż więcej
Źródło:
International urology and nephrology [Int Urol Nephrol] 2023 Nov; Vol. 55 (11), pp. 2765-2772. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Nerve Block*
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Humans ; Obturator Nerve/pathology ; Transurethral Resection of Bladder ; Urologic Surgical Procedures
Czasopismo naukowe
Szczegóły
Tytuł:
Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer.
Autorzy:
Reignier PL; Urology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Gauthier H; Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Hennequin C; Radiotherapy Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Aussedat Q; Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Xylinas E; Urology Department, Bichat-Claude Bernard Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Desgrandchamps F; Urology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Culine S; Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Masson-Lecomte A; Urology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France.
Dumont C; Medical Oncology Department, Saint-Louis Hospital, AP-HP.Nord Université Paris Cité, Paris, France. .
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2023 Nov; Vol. 41 (11), pp. 3249-3255. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder*/pathology
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Cystectomy ; Neoadjuvant Therapy ; Retrospective Studies ; Muscles ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Editorial Comment to Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG-treated disease.
Autorzy:
Goto Y; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Nov; Vol. 30 (11), pp. 957-958. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/surgery
Carcinoma, Transitional Cell*/therapy
Humans ; BCG Vaccine/therapeutic use ; Risk Assessment ; Neoplasm Invasiveness ; Administration, Intravesical ; Neoplasm Recurrence, Local ; Adjuvants, Immunologic/therapeutic use
Opinia redakcyjna
Szczegóły
Tytuł:
HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.
Autorzy:
Dou X; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Ma X; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Meng W; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Zhang W; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Yang S; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Niu F; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China.; College of Life Science, Northwest University, Xi'an, 710069, Shaanxi, China.
Xiong Y; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China. .; Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China. .
Jin T; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Northwest University, Xi'an, 710069, Shanxi, China. .; Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, 710069, Shaanxi, China. .
Pokaż więcej
Źródło:
Molecular genetics and genomics : MGG [Mol Genet Genomics] 2023 Nov; Vol. 298 (6), pp. 1353-1364. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:
Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/genetics
Proto-Oncogene Proteins c-akt*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Female ; Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Cycle/genetics
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 27401

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies